PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years-Reference-Cited by-同舟云学术

PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years

Published:2015-01 Issue:1 Volume:18 Page:19467
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Strehlau Renate,Donati Anamaria Pena,Arce Pedro Martinez,Lissens Jurgen,Yang Rong,Biguenet Sophie,Cambilargiu Daniela,Hardy Hélène,Correll Todd

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.7448/IAS.18.1.19467/fullpdf

Reference41 articles.

1. UNICEF. UNICEF data: monitoring the situation of children and women [Internet] 2013 http://data.unicef.org/hiv-aids/global-trends

2. Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life;Gray;Pediatrics,2001

3. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a metaanalysis;Dunn;Lancet,2003

4. Early antiretroviral therapy and mortality among HIV-infected infants;Violari;N Engl J Med,2008

5. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era;Brady;J Acquir Immune Defic Syndr,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review;Frontiers in Pediatrics;2022-05-23

2. Lopinavir-Ritonavir Impairs Adrenal Function in Infants;Clinical Infectious Diseases;2019-10-21

3. Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV;Therapeutic Drug Monitoring;2019-08

4. Pediatric Antiretroviral Therapy;Handbook of Experimental Pharmacology;2019

5. Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-08-15